Inherited proliferative vitreoretinopathies of childhood

International Ophthalmology Clinics

Volumn 48, Issue 2, 2008, Pages 159-174

  Andreoli, Christopher M ^a   Warden, Scott M ^a   Mukai, Shizuo ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; I KAPPA B KINASE GAMMA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; PROTEIN FZD 4; PROTEIN NORRIE; SECRETED FRIZZLED RELATED PROTEIN 4; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY; WNT PROTEIN;

AUTOSOMAL DOMINANT DISORDER; B WAVE; CATARACT; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR DISEASE; CHILDHOOD DISEASE; CLINICAL FEATURE; CORNEA OPACITY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EARLY INTERVENTION; ELECTRORETINOGRAM; EXUDATIVE RETINITIS; FAMILIAL EXUDATIVE VITREORETINOAPTHY; GENETIC COUNSELING; GROWTH RETARDATION; HUMAN; HYPOGONADISM; IMMUNE DEFICIENCY; INCONTINENTIA PIGMENTI; KERATINOCYTE; LASER COAGULATION; LEUKOKORIA; LUNG TUBERCULOSIS; MENTAL DEFICIENCY; MICROCEPHALY; MISSENSE MUTATION; MOLECULAR GENETICS; MYOPIA; NEOVASCULAR INFLAMMATORY VITREORETINOPATHY; NONHUMAN; NORRIE DISEASE; OPTIC NERVE ATROPHY; PARALYSIS; PATHOGENESIS; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETINA DISEASE; RETINA EXUDATE; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RETINA PIGMENT EPITHELIOPATHY; RETINOSCHISIS; REVIEW; SEIZURE; SKULL MALFORMATION; STRABISMUS; TOOTH MALFORMATION; VEIN INSUFFICIENCY; VERTEBRA MALFORMATION; VISUAL ACUITY; VITREORETINOPATHY; VITREOUS HEMORRHAGE; X CHROMOSOME LINKED DISORDER;

CHILD; CHILD, PRESCHOOL; HUMANS; VITREORETINOPATHY, PROLIFERATIVE;

EID: 42449085912     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181692cd4     Document Type: Review

References (87)

1. Criswick VG, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol. 1969;68:578-594.
2. Tasman W, Augsburger JJ, Shields JA, et al. Familial exudative vitreoretinopathy. Trans Am Ophthalmol Soc. 1981;79:211-226.
3. Nijhuis FA, Deutman AF, Aan de Kerk AL. Fluorescein angiography in mild stages of dominant exudative vitreoretinopathy. Mod Probl Ophthalmol. 1979;20:107-114.
4. van Nouhuys CE. Juvenile retinal detachment as a complication of familial exudative vitreoretinopathy. Fortschr Ophthalmol. 1989;86:221-223.
5. Miyakubo H, Inohara N, Hashimoto K. Retinal involvement in familial exudative vitreoretinopathy. Ophthalmologica. 1982;185:125-135.
6. Hashimoto K, Miyakubo H, Inohara N, et al. Juvenile retinal detachment and familial exudative vitreoretinopathy. Jpn J Clin Ophthalmol. 1983;37:797-803.
7. Benson WE. Familial exudative vitreoretinopathy. Trans Am Ophthalmol Soc. 1995;93:473-521.
8. Dudgeon J. Familial exudative vitreo-retinopathy. Trans Ophthalmol Soc UK. 1979;99:45-49.
9. Nishimura M, Yamana T, Sugino M, et al. Falciform retinal fold as sign of familial exudative vitreoretinopathy. Jpn J Ophthalmol. 1983;27:40-53.
10. van Nouhuys CE. Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina. Doc Ophthalmol. 1982;54:1-414.
11. Campo RV. Similarity of familial exudative vitreoretinopathy and retinopathy of prematurity. Arch Ophthalmol. 1983;101:821.
12. Ebert EM, Mukai S. Familial exudative vitreoretinopathy. Int Ophthalmol Clin. 1993;33:237-247.
13. Canny CL, Oliver GL. Fluorescein angiographic findings in familial exudative vitreoretinopathy. Arch Ophthalmol. 1976;94:1114-1120.
14. Azuara-Blanco A, Pesin SR, Katz LJ, et al. Familial exudative vitreoretinopathy associated with nonneovascular chronic angle-closure glaucoma. J Glaucoma. 1997;6:47-49.
15. Li Y, Fuhrmann C, Schwinger E, et al. The gene for autosomal dominant familial exudative vitreoretinopathy (Criswick-Schepens) on the long arm of chromosome 11. Am J Ophthalmol. 1992;113:712-713.
16. Robitaille J, MacDonald ML, Kaykas A, et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet. 2002;32:326-330.
17. Riveiro-Alvarez R, Trujillo-Tiebas MJ, Gimenez-Pardo A, et al. Genotype-phenotype variations in five Spanish families with Norrie disease or X-linked FEVR. Mol Vis. 2005;11:705-712.
18. Shastry BS, Hejtmancik JF, Trese MT. Identification of novel missense mutations in the Norrie disease gene associated with one X-linked and four sporadic cases of familial exudative vitreoretinopathy. Hum Mutat. 1997;9:396-401.
19. Shastry BS, Pendergast SD, Hartzer MK, et al. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol. 1997;115:651-655.
20. Toomes C, Downey LM, Bottomley HM, et al. Identification of a fourth locus (EVR4) for familial exudative vitreoretinopathy (FEVR). Mol Vis. 2004;10:37-42.
21. Qin M, Hayashi H, Oshima K, et al. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes. Hum Mutat. 2005;26:104-112.
22. Jiao X, Ventruto V, Trese MT, et al. Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. Am J Hum Genet. 2004;75:878-884.
23. Pinson KI, Brennan J, Monkley S, et al. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature. 2000;407:535-538.
24. Downey LM, Keen TJ, Roberts E, et al. A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13. Am J Hum Genet. 2001;68:778-781.
25. Toomes C, Downey LM, Bottomley HM, et al. Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree. Br J Ophthalmol. 2005;89:194-197.
26. de Crecchio G, Simonelli F, Nunziata G, et al. Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity. Clin Genet. 1998;54:315-320.
27. Gow J, Oliver GL. Familial exudative vitreoretinopathy. An expanded view. Arch Ophthalmol. 1971;86:150-155.
28. Laqua H. Familial exudative vitreoretinopathy. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980;213:121-133.
29. Chaudhuri PR, Rosenthal AR, Goulstine DB, et al. Familial exudative vitreoretinopathy associated with familial thrombocytopathy. Br J Ophthalmol. 1983;67:755-758.
30. Friedrich CA, Francis KA, Kim HC. Familial exudative vitreoretinopathy (FEVR) and platelet dysfunction. Br J Ophthalmol. 1989;73:477-478.
31. Gole GA, Goodall K, James MJ. Familial exudative vitreoretinopathy. Br J Ophthalmol. 1985;69:76.
32. Gitter KA, Rothschild H, Waltman DD, et al. Dominantly inherited peripheral retinal neovascularization. Arch Ophthalmol. 1978;96:1601-1605.
33. van Nouhuys CE. Congenital retinal fold as a sign of dominant exudative vitreoretinopathy. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1981;217:55-67.
34. Chang-Godinich A, Paysse EA, Coats DK, et al. Familial exudative vitreoretinopathy mimicking persistent hyperplastic primary vitreous. Am J Ophthalmol. 1999;127:469-471.
35. Bergen RL, Glassman R. Familial exudative vitreoretinopathy. Ann Ophthalmol. 1983;15:275-276.
36. Tano Y, Ikeda T. Treatment of familial exudative vitreoretinopathy with pars plana vitrectomy. Ophthalmology. 1990;97(suppl):152.
37. Andersen SR, Warburg M. Norrie's disease: congenital bilateral pseudotumor of the retina with recessive X-chromosomal inheritance; preliminary report. Arch Ophthalmol. 1961;66:614-618.
38. Warburg M. Norrie's disease. A congenital progressive oculo-acoustico-cerebral degeneration. Acta Ophthalmol (Copenh). 1966;44(suppl 89):1-47.
39. Norrie G. Nogle Blindhedsaarsager: en oversigt. Hospitalstidende. 1933;76:141-147.
40. Warburg M. Norrie's disease-differential diagnosis and treatment. Acta Ophthalmol (Copenh). 1975;53:217-236.
41. Michaelides M, Luthert PJ, Cooling R, et al. Norrie disease and peripheral venous insufficiency. Br J Ophthalmol. 2004;88:1475.
42. Apple DJ, Fishman GA, Goldberg MF. Ocular histopathology of Norrie's disease. Am J Ophthalmol. 1974;78:196-203.
43. Schroeder B, Hesse L, Bruck W, et al. Histopathological and immunohistochemical findings associated with a null mutation in the Norrie disease gene. Ophthalmic Genet. 1997;18:71-77.
44. Parsons MA, Curtis D, Blank CE, et al. The ocular pathology of Norrie disease in a fetus of 11 weeks' gestational age. Graefes Arch Clin Exp Ophthalmol. 1992;230:248-251.
45. Andreoli CM, Maumenee IH, Zhu D, et al. Histopathology and electron microscopy of a 16-week gestation retina carrying the Norrie mutation. IOVS. 2004;45(E-Abstract 2502).
46. Chynn EW, Walton DS, Hahn LB, et al. Norrie disease. Diagnosis of a simplex case by DNA analysis. Arch Ophthalmol. 1996;114:1136-1138.
47. Joos KM, Kimura AE, Vandenburgh K, et al. Ocular findings associated with a Cys39Arg mutation in the Norrie disease gene. Arch Ophthalmol. 1994;112:1574-1579.
48. Berger W, Meindl A, van de Pol TJ, et al. Isolation of a candidate gene for Norrie disease by positional cloning. Nat Genet. 1992;2:84.
49. Chen ZY, Hendriks RW, Jobling MA, et al. Isolation and characterization of a candidate gene for Norrie disease. Nat Genet. 1992;1:204-208.
50. Black GC, Perveen R, Bonshek R, et al. Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for Norrin in retinal angiogenesis. Hum Mol Genet. 1999;8:2031-2035.
51. Berger W, van de Pol D, Warburg M, et al. Mutations in the candidate gene for Norrie disease. Hum Mol Genet. 1992;1:461-465.
52. Chen ZY, Battinelli EM, Fielder A, et al. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet. 1993;5:180-183.
53. Meitinger T, Meindl A, Bork P, et al. Molecular modelling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure. Nat Genet. 1993;5:376-380.
54. Xu Q, Wang Y, Dabdoub A, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell. 2004;116:883-895.
55. Tawansy KA. Macular features of pediatric surgical vitreoretinal diseases. Ophthalmol Clin North Am. 2002;15:503-516, vii.
56. Cohen PR. Incontinentia pigmenti: clinicopathologic characteristics and differential diagnosis. Cutis. 1994;54:161-166.
57. Minic S, Novotny GE, Trpinac D, et al. Clinical features of incontinentia pigmenti with emphasis on oral and dental abnormalities. Clin Oral Investig. 2006;10:343-347.
58. Lee AG, Goldberg MF, Gillard JH, et al. Intracranial assessment of incontinentia pigmenti using magnetic resonance imaging, angiography, and spectroscopic imaging. Arch Pediatr Adolesc Med. 1995;149:573-580.
59. Scott JG, Friedmann AI, Chitters M, et al. Ocular changes in the Bloch-Sulzberger syndrome (incontinentia pigmenti). Br J Ophthalmol. 1955;39:276-282.
60. Holmstrom G, Thoren K. Ocular manifestations of incontinentia pigmenti. Acta Ophthalmol Scand. 2000;78:348-353.
61. Goldberg MF, Custis PH. Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome). Ophthalmology. 1993;100:1645-1654.
62. Goldberg MF. Macular vasculopathy and its evolution in incontinentia pigmenti. Trans Am Ophthalmol Soc. 1998;96:55-65; discussion 65-72.
63. Fard AK, Goldberg MF. Persistence of fetal vasculature in the eyes of patients with incontinentia pigment. Arch Ophthalmol. 1998;116:682-684.
64. Zweifach PH. Incontinentia pigmenti: its association with retinal dysplasia. Am J Ophthalmol. 1966;62:716-722.
65. Pollard ZF. Results of treatment of persistent hyperplastic primary vitreous. Ophthalmic Surg. 1991;22:48-52.
66. Parrish JE, Scheuerle AE, Lewis RA, et al. Selection against mutant alleles in blood leukocytes is a consistent feature in Incontinentia Pigmenti type 2. Hum Mol Genet. 1996;5:1777-1783.
67. Ardelean D, Pope E. Incontinentia pigmenti in boys: a series and review of the literature. Pediatr Dermatol. 2006;23:523-527.
68. Pacheco TR, Levy M, Collyer JC, et al. Incontinentia pigmenti in male patients. J Am Acad Dermatol. 2006;55:251-255.
69. Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000;405:466-472.
70. Jin DY, Jeang KT. Isolation of full-length cDNA and chromosomal localization of human NF-kappaB modulator NEMO to Xq28. J Biomed Sci. 1999;6:115-120.
71. Sefiani A, Abel L, Heuertz S, et al. The gene for incontinentia pigmenti is assigned to Xq28. Genomics. 1989;4:427-429.
72. Yamaoka S, Courtois G, Bessia C, et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998;93:1231-1240.
73. Rothwarf DM, Zandi E, Natoli G, et al. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature. 1998;395:297-300.
74. Jelinek JE, Bart RS, Schiff SM. Hypomelanosis of Ito ("incontinentia pigmenti achromians"). Report of three cases and review of the literature. Arch Dermatol. 1973;107:596-601.
75. Bennett SR, Folk JC, Kimura AE, et al. Autosomal dominant neovascular inflammatory vitreoretinopathy. Ophthalmology. 1990;97:1125-1135; discussion 1135-1136.
76. Stone EM, Kimura AE, Folk JC, et al. Genetic linkage of autosomal dominant neovascular inflammatory vitreoretinopathy to chromosome 11q13. Hum Mol Genet. 1992;1:685-689.
77. Kaufman SJ, Goldberg MF, Orth DH, et al. autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol. 1982;100:272-278.
78. Lafaut BA, Loeys B, Leroy BP, et al. Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree. Graefes Arch Clin Exp Ophthalmol. 2001;239:575-582.
79. Kellner U, Jandeck C, Kraus H, et al. Autosomal dominant vitreoretinochoroidopathy with normal electrooculogram in a German family. Graefes Arch Clin Exp Ophthalmol. 1998;236:109-114.
80. Traboulsi EI, Payne JW. Autosomal dominant vitreoretinochoroidopathy. Report of the third family. Arch Ophthalmol. 1993;111:194-196.
81. Roider J, Fritsch E, Hoerauf H, et al. Autosomal dominant vitreoretinochoroidopathy. Retina. 1997;17:294-299.
82. Blair NP, Goldberg MF, Fishman GA, et al. Autosomal dominant vitreoretinochoroidopathy (ADVIRC). Br J Ophthalmol. 1984;68:2-9.
83. Oh KT, Vallar C. Central cone dysfunction in autosomal dominant vitreoretinochoroidopathy (ADVIRC). Am J Ophthalmol. 2006;141:940-943.
84. Han DP, Lewandowski MF. Electro-oculography in autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol. 1992;110:1563-1567.
85. Yardley J, Leroy BP, Hart-Holden N, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci. 2004;45:3683-3689.
86. Goldberg MF, Lee FL, Tso MO, et al. Histopathologic study of autosomal dominant vitreoretinochoroidopathy. Peripheral annular pigmentary dystrophy of the retina. Ophthalmology. 1989;96:1736-1746.
87. Han DP, Burke JM, Blair JR, et al. Histopathologic study of autosomal dominant vitreoretinochoroidopathy in a 26-year-old woman. Arch Ophthalmol. 1995;113:1561-1566.